Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
University of Florida
Children's Hospital Los Angeles
Baylor College of Medicine
Seattle Children's Hospital
Seattle Children's Hospital
University Hospital Southampton NHS Foundation Trust
Eli Lilly and Company
Seattle Children's Hospital
Baylor College of Medicine
New Approaches to Neuroblastoma Therapy Consortium